Skip to main content
. 2021 May 13;4:571. doi: 10.1038/s42003-021-02089-y

Fig. 2. Characterization of SETDB1- and SUV39H1/2-dependent H3K9me2 regions in iMEFs.

Fig. 2

a Representative view of H3K9me2 ChIP-seq data along chromosome 6 in iMEFs. Although H3K9me2 in the A compartments is decreased by UNC0642 treatment, low H3K9me2 signal is retained. Those retained H3K9me2 is further diminished in UNC0642-treated Setdb1 KO iMEFs. b Difference in G9a/GLP-independent H3K9me2 between mESCs and iMEFs. H3K9me2 domain size is larger in iMEFs than in mESCs. c A comparison between compartment score and H3K9me2 changes by UNC0642 treatment in iMEFs. Overall, H3K9me2 reduction in the A compartments is induced by the UNC0642 treatment. Each plot represents data from each 80-kb bin. Darker blue represents higher dot density. d Fractions of H3K9me2 domains in the A and B compartments in UNC0642-treated iMEFs. e A comparison between compartment score and H3K9me2 changes in UNC0642-treated Setdb1 KO iMEFs. In comparison with UNC0642-treated WT iMEFs (c), UNC0642-treated Setdb1 KO iMEFs showed further reduction of H3K9me2, especially in the A compartments. f The number and the length of H3K9me2 domains in WT and Setdb1 KO iMEFs treated with UNC0642. Both the number and the length of H3K9me2 domains in the A compartments are reduced in UNC0642-treated Setdb1 KO iMEFs. g H3K9me2 ChIP-qPCR analysis in regions showing in Supplementary Fig. 1o. H3K9me2 in the region 1 and 2 is completely lost in UNC0642-treated TKO iMEFs. Data are mean ± SEM; n = 3.